Abstract. Thoracic aortic dissection (TAD) is a life-threatening vascular condition, in which matrix metalloproteinases (MMPs) are involved. Since the key determinants underlying MMP action remain elusive, the present study investigated the correlation between single nucleotide polymorphisms (SNPs) in the promoter region of the MMP-8 gene and a predisposition to TAD, by comparing genotypes of TAD patients and healthy controls. From 154 TAD patients and 148 healthy individuals, DNA samples were obtained from venous blood, and genotyping was performed by a combination of polymerase chain reaction and automatic sequencing to detect SNPs in the MMP-8 promoter. Data were analyzed and odds ratios (OR) and 95% confidence intervals (CI) were calculated. P<0.05 was considered to indicate a statistically significant result. Two SNPs, -799C/T and -767A/T, were identified in the MMP-8 promoter. Distribution of the -767A/T genotype was not significantly different between the patients and healthy controls.
Introduction
Thoracic aortic dissection (TAD) is a life-threatening vascular condition, associated with a number of genetic factors that have been hypothesized to contribute to disease susceptibility (1) . Recent studies on the genetic background of familial thoracic aortic aneurysms (TAAs) have focused on their association with connective tissue disorders, such as Marfan syndrome (2) and Ehlers-Danlos syndrome (3) . Several studies have demonstrated that the development of aneurysmal disease may be linked to a number of genetic characteristics (4, 5) . Up to 19% of patients with non-syndromic TAA have first-degree relatives affected by the disease, suggesting that genetic background is critical in the development of TAAs (6) . Notably, environmental factors, including age, smoking, hypertension, hypercholesterolemia, and inflammatory and autoimmune disorders also significantly affect aortic structure, and thus also contribute to the development and progression of aortic disease (7) .
The onset and development of TAD have been attributed to the breakdown of collagen and elastic fibers, loss of smooth muscle cells and accumulation of basophilic amorphous deposits (8) . Although the histological characteristics of the dilated thoracic aorta may vary, they are underlined by the same pathophysiological mechanisms (9) . Currently, studies investigating the processes involved in thoracic aorta aneurysms focus on the degradation of elastin, loss of smooth muscle cells and elevated concentrations of matrix metalloproteinases (MMPs) (10) . Overexpression of MMPs produced by smooth muscle cells may contribute to the pathological alterations of the extracellular matrix (ECM) and therefore result in the dissection of the aorta (11) . There is a prominent increase of MMP-8 and MMP-9 in the plasma of patients in the acute and subacute phases of TAD (12) , as well as at the site of the ruptured aortic wall in patients with abdominal aneurysms (13) . Furthermore, it has been demonstrated that the -1562C/T polymorphism in the promoter region of MMP-9 is associated with the development of aortic dissection with hyperpiesia, and that this polymorphism may increase patient predisposition to the condition (14) .
A promoter is a specific DNA region that lies upstream of the gene and binds to transcription factors, and is therefore critically involved in the regulation of the gene and its subsequent protein expression. It was hypothesized that polymorphisms within the promoter region of MMP-8 may have an impact on the MMP-8 transcription in patients with TAD. (15) , or the association between MMP-2, MMP-3, MMP-9 and MMP-12, and thoracic aortic aneurysms and TAD (7, 16, 17) . However, limited data are available regarding the association of MMP-8 polymorphisms with TAD. In the present study, the correlation between single nucleotide polymorphisms (SNPs) in the MMP-8 promoter and TAD were investigated. For this, the promoter region of MMP-8 was amplified, sequenced and analyzed in a population comprised of patients with TAD and healthy individuals as the controls.
Subjects and methods
Patients. In total, 154 patients were selected with acute TAD that had been admitted to Shandong Provincial Hospital (Shandong, China) for participation in the present study. For all patients, the diagnosis was confirmed by enhanced computed tomography. The type of aortic dissection was determined according to the Stanford classification (18): 51 patients had type A and 103 patients had type B. Furthermore, 148 healthy individuals were selected as the reference control group from outpatients who complained of chest pain or underwent medical examinations, but did not have cancer, cardiovascular conditions or genetic diseases. All subjects were of Han ethnicity, with no familial relationship between them. Clinical variables included age, gender, type of dissection, body mass index (BMI), hyperpiesia, smoking habits and the presence of diabetes mellitus. Characteristics of patients with TAD and control individuals are listed in Table I . The study was approved by the Ethics Committee of Shandong Provincial Hospital (Jinan, China) and all participants provided written informed consent.
Genotyping of SNPs in the MMP-8 promoter.
Blood samples were collected in EDTA-containing tubes and DNA was extracted using the Bloodready™ Multiplex PCR system (GenScript USA Inc., Piscataway, NJ, USA) according to the manufacturer's instructions. The MMP-8 promoter fragments were amplified using two pairs of primers designed on human MMP-8 promoter sequences (GenBank accession no. AF059679). The primer sequences used are shown in Table II .
Polymerase chain reaction (PCR) was performed in a 20-µl reaction volume containing 1 µl genomic DNA, 4 µM of each primer, 7.2 µl water, 0.4 µl dNTPs, 10X reaction buffer and 0.4 µl Taq polymerase ('HotStart'Script™; GenScript USA Inc., Piscataway, NJ USA), and the insufficient part was filled up with water in the 9600 GeneAmp PCR thermal cycler (GenScript USA Inc.). The amplified fragments were sequenced using an ABI 377 sequencer (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions. The primer sequences, annealing temperatures and the sizes of the PCR products are presented in Table II . The reaction mixture was denatured for 1.5 min at 94˚C, annealed for 30 sec at 55˚C or at 60˚C, extended for 1 min at 72˚C (35 cycles), and extended for another 5 min at 72˚C.
Statistical analysis. Data were analyzed using the SPSS version 13.0. statistical package for Windows (SPSS Inc. Chicago, IL, USA). Hardy-Weinberg equilibrium among control subjects was evaluated using observed genotype frequencies and 
Results
Allele and genotype distribution of -799C/T in patients and controls. Two SNPs, -799C/T and -767A/T, were identified in the MMP-8 promoter region (Figs. 1-4) . The distribution of the -799C/C, -799C/T and -799T/T genotypes was 54.5, 37.7 and 7.8% in the TAD group, and 76.4, 20.3 and 3.3% in the control group, respectively. The -799C/C genotype was utilized as a reference group, and there was a significant difference in the genotype distribution between the TAD and control groups (P=0.000 and 0. Table III ). The genotype distribution followed the Hardy-Weinberg equilibrium.
Allele and genotype distribution of -767A/T in patients and controls.
The distribution of the -767A/A, -767A/T and -767T/T genotypes was 81.8, 16.9 and 1.3% in the TAD population, and 84.5, 13.5 and 2.0% in the control population, respectively. There was no significant difference between the distribution of the -767A/T and -767T/T genotype in the TAD and control groups Table IV ). The genotypic distribution followed the Hardy-Weinberg equilibrium. Further analysis of the -799C/T polymorphic site by Stanford classification also revealed no significant differences (Table V) .
Discussion
MMPs are members of a family of endopeptidases that process and degrade ECM proteins in connective tissues. MMPs are widely considered to be key regulatory factors in normal cellular physiology, as they are able to establish specialized microenvironments for cell differentiation, migration and invasion, and facilitate in the determination of cell survival and destruction (19) . MMP-1, MMP-8 and MMP-13 are collagenases that degrade interstitial collagens of the ECM. The turnover and remodeling of the ECM is a highly regulated process, as uncontrolled proteolysis results in abnormalities that lead to the development of pathological diseases including TAA, which is characterized by excessive degradation of the ECM components.
To accomplish their normal or pathological function, MMPs must be produced by the appropriate cell type and within the correct pericellular region, in a time-and concentration-dependent manner. In addition, the activity of MMPs is highly regulated at the transcriptional, post-transcriptional (via mRNA stabilization), translational and post-translational (activation of the pro-MMP precursor zymogens) levels. Furthermore, MMP activity is regulated through the control of levels present within the tissue (by means of secretory regulation) or through the interaction with local tissue inhibitors (20) . Li et al (21) revealed a significant elevation in MMP-8 levels in the plasma of patients in the acute phase of TAD. This overexpression suggests that the polymorphisms altering MMP-8 expression contribute to patient susceptibility to TAD, however, the mechanisms underlying this effect remain unclear. Current studies are now focusing on genetic regulatory mechanisms, particularly the effect of SNPs on patient predisposition to TAD. For example, MMP gene expression may be affected by tumor necrosis factor-α (TNF-α), through the activation of transcription factors that bind to specific response elements on the promoters of the MMP genes (22) . Furthermore, genetic variations in the MMP-8 promoter region may contribute to the MMP-8 expression, and thus, to increased risk of preterm premature rupture of fetal membranes (23) .
Polymorphisms are DNA sequence variants that are present in at least 1% of the population when the variant is first observed. (24) . A study has revealed the presence of consensus sequences of nuclear binding proteins on the promoter regions of collagenase and stromelysin genes, including the phorbol ester-responsive element and AP-1 binding site (25). A promoter is a DNA region recognized by RNA polymerase that initiates gene transcription. In the process of RNA synthesis, the promoter interacts with transcription factors that initiate gene transcription and thus regulates protein expression. MMP-8 expression is mainly regulated at the transcriptional level, thus, SNPs in the promoter region promote gene transcription activity, resulting in significantly increased protein expression. It has been confirmed that expression of MMP-9 mRNA in patients with the -1562T/C allele is five times higher than in those with the C/C allele (26) . These data demonstrated that mutations in the T allele promote the expression of MMPs.
In the present study, two SNPs, -799C/T and -767A/T, were identified in the MMP-8 promoter region. The frequencies of the -799C/T and -799T/T genotypes in patients with TAD were significantly higher and the T allele distribution was also considerably elevated, as compared with that in the control subjects. Based on the calculated OR and 95% CI, it may be concluded that these SNPs correlate with the incidence of TAD and that patients with the T allele have a relatively higher predisposition to TAD. However, no correlation was identified between the -767A/T genotype and TAD.
In conclusion, these data demonstrated that while no correlation was observed between the -767A/T SNP and TAD, there was an evident association between the -799C/T polymorphism in the MMP-8 gene and the incidence of TAD. Furthermore, the presence of the T allele may enhance susceptibility to aortic dissection. Understanding the genetic characteristics of TAD, will facilitate the improvement of diagnostic and treatment strategies for the future.
